BioSpace News Archive

Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating Assertio Therapeutics, Inc. (“Assertio Therapeutics” or the “Company”) (NasdaqGS: ASRT) relating to the creation of a combined company between the C

Rebound hypoglycemia observed in the placebo arm with oral glucose tablet use; No rebound hypoglycemia observed in the RTU glucagon treatment arm CHICAGO--( BUSINESS WIRE )-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced positive findings from the outpatient stage of a Phase 2

Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the upcoming virtual presentation on the development of novel therapeutics focused on treating Central Nervous System (CNS) indications via the gut-brain axis at the American Society of Clinical Psychopharmacology (ASCP) 2020 Annual Mee

Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it will host the Company’s 2020 Annual Meeting of Stockholders (the “Annual Meeting”) virtually due to public health concerns resulting from the coronavirus (“COVID-19”) outbreak, and government-recommended and required limits on public gatherings. Holding the meeting online will also protect the health and sa

MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of healthcare industry executive Damon Goodwin as Global Director of Sales, effective immediately. Mr. Goodwin will play an integral part in MedX’s revenue growth by building global partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in Mexico, Brazil and the USA, he will also b

Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development Co., Ltd. (“Sinovac R&D”), a wholly owned subsidiary of Sinovac, to further the development of an inactivated vaccine against COVID-19 named CoronaVac. The two investors

- Foundation celebrates second regulatory approval from funded portfolio with FDA decision on Kynmobi for “off” time in Parkinson’s disease - Approval is proof of impact for MJFF’s unique investment strategy that “de-risks” early-stage projects for larger partners [22-May-2020] NEW YORK , May 22, 2020 /PRNewswire/ -- The Michael J. Fox Fo

Kennedy Lewis Investment Management (“Kennedy Lewis”), an opportunistic credit manager, completed a significant commitment to Rapid Micro Biosystems, Inc. (“Rapid Micro”) in the form of a senior secured debt facility as part of the recent $120 million total debt and equity financing.

Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 5,000,000 shares of the Company’s c

The WHO’s COVID-19 webpage will feature a search bar powered by Yext Answers, where site visitors can access official information about COVID-19.